Sun Pharma shares fall 4% as management guides for single-digit revenue growth

Notably, the management said that spending on R&D expenses will rise to 10% of revenue from 6-7% to aid its specialty portfolio

Related Keywords

Halol ,Gujarat ,India ,Dadra ,Dadra And Nagar Haveli ,Mohali ,Madhya Pradesh ,Sun Pharma ,Sun Pharmaceutical Industries ,National Stock Exchange ,Prescription Drug User Fee Act ,